Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age

• Published in: Journal of ovarian research 2020-11, Vol.13 (1), p.137-137, Article 137
• Main Authors: O'Brien, Jacob, Du, Kevin Y, Peng, Chun
• Format: Article
• Language: English
• Subjects: Adult; Age Factors; Aged; Canada - epidemiology; Care and treatment; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - therapy; COVID-19 - virology; Estrogen; Estrogens; Fatalities; Female; Females; Gender differences; Health aspects; Health care; Humans; Long-term care of the sick; Male; Males; Medical personnel; Middle Aged; Pandemics; Patients; Post-menopause; Postmenopausal women; Risk Factors; Risk groups; SARS-CoV-2 - pathogenicity; Sex; Sex Characteristics; Sex differences; Young Adult
• ISSN: 1757-2215; 1757-2215
• DOI: 10.1186/s13048-020-00734-4

Male sex and older age have been reported to be associated with worse outcomes from COVID-19. It was postulated that estrogens may play a role in reducing the severity of the disease and may therefore offer a treatment option for COVID-19 patients. However, more female cases and deaths from COVID-19 have been recorded in Canada. To determine the potential role of estrogens, we analyzed COVID-19 data from Canada, focusing on the impact of sex and age. Although the overall incidence rate is higher in females than in males, when several high risk groups, including health care workers and long-term care residences, which are predominantly females, were excluded, we found that females had a lower incidence rate than males between the ages of 20s to 70s. Interestingly, this sex-based difference is more evident in females of the reproductive ages (20-49) than in postmenopausal patients (60s or older). Males have significantly higher hospitalization, ICU admission, and case fatality rates; however, a greater difference was observed in the older age groups. Finally, symptom manifestation varied between sexes. Some of the symptoms, which were more frequently observed in patients who recovered than patients who died, were more commonly observed in females of the reproductive age compared to their male counterparts. Since only females of the reproductive age have much higher circulating estrogens than males, these findings suggest that estrogens may play a role in reducing COVID-19 incidence and in the development of symptoms, especially those related to better survival.